Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...
1d
Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...
All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback